Clinical outcomes of keratitis

Clinical and Experimental Ophthalmology

Volumn 35, Issue 5, 2007, Pages 421-426

  Green, Matthew D ^a,b,d   Apel, Andrew J G ^c   Naduvilath, Thomas ^c   Stapleton, Fiona J ^b,c  

^a Gold Coast Hospice   (United States)

^b Princess Alexandra Hospital   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d NONE   (Australia)

Author keywords

Cephalosporin; Contact lens; Pseudomonas; Resistance

Indexed keywords

ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; BACTERIUM ISOLATION; CONFIDENCE INTERVAL; CONTACT LENS; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DISEASE SEVERITY; ENUCLEATION; EVISCERATION; EYE DISEASE; EYE SURGERY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; KERATITIS; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PENETRATING KERATOPLASTY; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 34547409876     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2007.01511.x     Document Type: Article

References (23)

1. Seal DV, Kirkness CM, Bennett HG, Peterson M. Population-based cohort study of microbial keratitis in Scotland: Incidence and features. Cont Lens Anterior Eye 1999; 22: 49-57.
2. Butler TK, Spencer NA, Chan CC et al. Infective keratitis in older patients: A 4 year review, 1998-2002. Br J Ophthalmol 2005; 89: 591-6.
3. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol 1987; 71: 96-101.
4. Keay L, Edwards K, Naduvilath T et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology 2006; 113: 109-16.
5. Gebauer A, McGhee CN, Crawford GJ. Severe microbial keratitis in temperate and tropical Western Australia. Eye 1996; 10: 575-80.
6. Ly CN, Pham JN, Badenoch PR et al. Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin. Clin Experiment Ophthalmol 2006; 34: 44-50.
7. Leibovitch I, Lai TF, Senarath L et al. Infectious keratitis in South Australia: Emerging resistance to cephazolin. Eur J Ophthalmol 2005; 15: 23-6.
8. Bourcier T, Thomas F, Borderie V et al. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 2003; 87: 834-8.
9. Miedziak AI, Miller MR, Rapuano CJ et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999; 106: 1166-70.
10. Hooi SH, Hooi ST. Culture-proven bacterial keratitis in a Malaysian general hospital. Med J Malaysia 2005; 60: 614-23.
11. Morlet N, Minassian D, Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group. Br J Ophthalmol 1999; 83: 1027-31.
12. Musch DC, Sugar A, Meyer RF. Demographic and predisposing factors in corneal ulceration. Arch Ophthalmol 1983; 101: 1545-8.
13. Gudmundsson OG, Ormerod LD, Kenyon KR et al. Factors influencing predilection and outcome in bacterial keratitis. Cornea 1989; 8: 115-21.
14. Titiyal JS, Negi S, Anand A et al. Risk factors for perforation in microbial corneal ulcers in north India. Br J Ophthalmol 2006; 90: 686-9.
15. Armstrong M. The laboratory investigation of infective keratitis. Br J Biomed Sci 1994; 51: 65-72.
16. Dart JK, Stapleton F, Minassian D. Contact lenses and other risk factors in microbial keratitis. Lancet 1991; 338: 650-3.
17. Steinberg EP, Tielsch JM, Schein OD et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol 1994; 112: 630-8.
18. Wong T, Ormonde S, Gamble G, McGhee CN. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003; 87: 1103-8.
19. National Cancer Institute - US National Institutes of Health. Levels of Evidence for Adult Cancer Treatment Studies. Accessed 26 Feb 2007. Available from: http://www.cancer.gov/cancertopics/pdq/ levels-evidence-adult-treatment
20. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology 2002; 109: 835-42.
21. Wilhelmus KR, Gee L, Hauck WW et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994; 101: 1883-95.
22. O'Brien WJ, Segundo AP, Guy J et al. Herpetic stromal disease: Response to acyclovir/steroid therapy. Acta Ophthalmol Scand 1996; 74: 265-70.
23. Keay L, Edwards K, Naduvilath T et al. Factors affecting the morbidity of contact lens-related microbial keratitis: A population study. Invest Ophthalmol Vis Sci 2006; 47: 4302-8.